Partnering opportunities

Clinical technology companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop clinical technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

99 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ | number }]} opportunities

99 opportunities

Get updates to this list Embed these results

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ }]}

Cloud-based solution for the financial management of clinical trials

Financial workflows in clinical trials involve several parties in various countries, tax and currency regions. All parties involved have to deal with many manual tasks, diverse data sources and non-standardized... more


Early treatment of epilepsy in newborn offered by a French clinical research team

A French clinical research team has developed an innovative treatment for paediatric epileptic seizures coming from a vitamin-sensitive effect. This research team is represented by a Technology Transfer Office... more


Allopurinol-based paediatric treatment of autistic disorders proposed by a French clinical research team

A French clinical research team has developped an innovative paediatric treatment for autistic disorders coming from a specific enzym deficiency. The team is represented by a Technology Transfer Office (TTO) which... more


A Swedish SME offers a unique computational methodology for virtual prediction of human clinical pharmacocinetics and metabolism

A Swedish SME, active in the area of pharmaceutical technology, has developed a unique platform, including software, for high quality predictions of human clinical ADME/PK (Absorption, Distribution, Metabolism,... more


H2020 - A French organisation offers its expertise and know-how in evaluation and clinical research in ageing, geriatrics and gerontology

prevention, care, technical assistance and training of health professionals. The French organisation has a strong expertise in clinical research and evaluation directly in the field: in geriatrics institutions... more


H2020-ICT-46-2020: Clinical partners (hospitals, nursing home) with the need of transporting patients or hospital supplies from one room to another within the hospital/nursing home

adverse impacts, including those due to human factor error (e.g., delays, falls, treatment interruption), as well as allowing a correct planning and execution of this assistive clinical process, while reducing... more


French pre-clinical biotech company offers its expertise in drug discovery and repurposing to identify personnalized medicine for patients with rare monogenetic diseases

The French company is a pre-clinical biotech company with a strong expertise in the fild of monogenetic disorders designing and developing miniaturised and automated in vitro cellular and phenotypic assays based... more


Non-internalizing, linker-less galectin-3 binding protein targeting antibody-drug conjugate for treatment of cancer

pharmacokinetics. The product is in pre-clinical stage of development. In order to submit the application for phase 1 trial, the following steps have to be performed: (i) generation of a stable antibody producing... more


A UK SME is looking for neonatal and paediatric hospitals for vital-sign remote monitoring collaboration under a technical cooperation agreement.

24/7 that allow having a clear image of the exact ongoing condition. Although some systems are available for use in clinical settings, there is not yet an option for parents to monitor signs reliably at home.... more

United Kingdom

A comprehensive platform for contract research laboratory services bundled with cutting-edge bioinformatics for cancer drug efficacy screening, biomarker discovery and patient stratification

An East of England company has developed a genomic platform to improve cancer treatment outcomes through advanced genetic screening technology. It aims at assisting both clinical oncologists and the researchers... more

United Kingdom

SC1-BHC-06-2020: Digital Diagnostics - biomarkers in psychiatry: Seeking coordinator

call for project SC1-BHC-06-2020: Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data. The Commission considers that proposals requesting a contribution... more


Molecular oncology diagnostic tool in targeted therapy

The Italian company offers a full range of histology and cytology tests for oncology. Stemming from the clinical experience the molecular tests are based on the choice of the most important genes involved in the... more


A novel human tumor endothelial marker 1 targeting antibody-drug conjugate for treatment of cancer

high in vivo activity against osteosarcoma xenografts in mice. The ADC has a good safety profile in treated animals. The product is in pre-clinical stage of development. In order to submit the application for... more


Actively targeted polymeric micelles for drug and gene delivery

of cancer and other complex diseases with an important genetic background. However, the in vivo delivery of oligonucleotides (OGN) has precluded the clinical use of gene-based therapies mainly due to its vulnerability... more


Development and manufacture of viral vectors for genetic vaccines and advanced therapies

through vectorization and transgene engineering. Additionally, the company has state-of-the-art technologies and expertise to evaluate the immunological responses to viral vectors in samples from preclinical models and clinical... more


Novel therapeutic approach in a multiplicity of neurodegenerative and autoinflammatory pathologies

numerous caspase-1 inhibitors have been synthesized, no inhibitor has passed the clinical trial, probably because of the covalent mechanism of action and the consequent unwanted off-target interactions. The research... more


Method for diagnosing Hereditary Hemorrhagic Telangiectasia (HHT)

propensity to hemorrhagic episodes. The current diagnosis is clinical, but the diagnosis is often delayed due to the gradual onset of symptoms. Thus, having a clinical suspicion,... more


UK-based SME offers biopolymer wound dressing to industrial partners under a license agreement

scale. This wound dressing technology has completed in vitro biocompatibility studies with good results. A clinical trial has been lined up to generate the data required for CE marking. The UK SME is looking... more

United Kingdom

A Phase 2a-stage drug for Huntington’s disease for license agreement

) orphan disease space—the company’s therapeutic focus. The company’s pipeline consists of clinical-stage assets for Huntington’s disease and Adrenoleukodystrophy, as well as preclinical-stage assets for Adrenomyeloneuropathy,... more


Novel drugs for the treatment of aging-related diseases like chronic wounds, glaucoma, skin fibrosis and skin-aging.

pressing need for innovative treatments. Based on preclinical studies on vascular smooth muscle cells, isolated organ studies and animal models, the low molecular weight clinical candidate of the Swiss biotech... more


The right partner not here?

Get in touch and we'll help you post a partnering opportunity